Project Details
Description
A Phase 3, Multi-Center, Randomized, Open Label, Parallel-Group Study of the Efficacy and Safety ofLenalidomide (Revlimid) Versus Chlorambucil as Fist Line Therapy for Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
| Status | Finished |
|---|---|
| Effective start/end date | 8/18/09 → 12/31/18 |
Funding
- CELGENE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.